Results 191 to 200 of about 24,071 (243)

Anti-VEGF versus laser therapy for retinopathy of prematurity: a systematic review and meta-analysis focusing on recurrence patterns and retreatment needs. [PDF]

Int J Retina Vitreous
Krungkraipetch L, Krungkraipetch D, Krungkraipetch K.   +2 more
europepmc   +1 more source

Correction to "Peptide-Bound Aflibercept Eye Drops for Treatment of Neovascular Age-Related Macular Degeneration in Nonhuman Primates". [PDF]

Adv Sci (Weinh)
europepmc   +1 more source

Aflibercept 8 mg versus Faricimab Treat-and-Extend for Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration: A Bayesian Fixed-Effect Network Meta-analysis of Clinical Trials. [PDF]

Ophthalmol Ther
Friedman SM, Xu Y, Sherman S, Kuznik A, Mojebi A, Keeping S, Chan K, Leng T, Patel N.   +8 more
europepmc   +1 more source

Intravitreal aflibercept 8 mg versus 2 mg in Asian patients with neovascular age-related macular degeneration: 48-week analysis of the Phase 3 PULSAR trial

Andrew Chang, Xiaodong Sun, Tomohiro Iida, Timothy Y. Y. Lai, Tien Y Wong, Chui Ming Gemmy Cheung, Won Ki Lee, Xin Zhang, Andrea Schulze, Ursula Schmidt-Ott, Min Zhao, Zoran Hasanbasic, Sergio Leal, Shih-Jen Chen   +13 more
openalex   +1 more source

Aflibercept, ranibizumab, and bevacizumab for macular neovascularization secondary to age-related macular degeneration: a retrospective OCT-angiography study. [PDF]

Int J Retina Vitreous
Lombardo M, Maccauro C, D'Ambrosio M, Grossi M, Missiroli F, Cesareo M, Ricci F.   +6 more
europepmc   +1 more source

Efficacy of aflibercept in vitrectomized vs. non-vitrectomized eyes with diabetic macular edema: a prospective study. [PDF]

Int J Retina Vitreous
Thury G, Baranyi N, Rárosi F, Héjja R, Kovács A.   +4 more
europepmc   +1 more source

Novel Needle for Intravitreal Injections Does Not Affect Biological Activity of Anti-VEGF Drugs. [PDF]

Clin Ophthalmol
Lytvynchuk L, Nolte KL, Fuezy I, Zhou W, Deissler H, Deissler HL.   +5 more
europepmc   +1 more source

Economic Benefit of Aflibercept 8 mg Versus Faricimab for Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema in the US. [PDF]

Ophthalmol Ther
Kuznik A, Coughlan A, Pinsent A, Toro-Diaz H, Sherman S, Patel N.   +5 more
europepmc   +1 more source

Predictive factors for the efficacy of brolucizumab in refractory polypoidal choroidal vasculopathy following aflibercept resistance. [PDF]

PLoS One
Yoshinaga A, Kitamoto K, Aoki S, Terao R, Inoue T, Obata R, Azuma K.   +6 more
europepmc   +1 more source